🔎 Trials Near Me

መነሻ › ካንሰር (ሁሉም ዓይነቶች) › South Carolina

በSouth Carolina ለካንሰር (ሁሉም ዓይነቶች) የሚደረጉ ክሊኒካዊ ጥናቶች

ለካንሰር (ሁሉም ዓይነቶች) የሚደረጉ 29 ጥናቶች በSouth Carolina ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በSouth Carolina ውስጥ ያሉ ከተሞች

Official study text (English)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Medical University of South Carolina, Florence
  • Medical University of South Carolina Health Lancaster Medical Center, Lancaster
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05920356

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • Prisma Health, Greenville
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06150157

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • SC Cancer Specialists at St. Joseph's/Candler Bluffton, Bluffton
  • St. Joseph's/Candler Smith, Bluffton
  • Summit Cancer Care at St. Josph's/Candler Bluffton, Bluffton
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT02693535

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

  • Medical University of South Carolina Hollings Cancer Center, Charleston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT07227610

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • Hematology and Oncology Associates of SC, LLC, Greenville
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT03435796

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • MUSC Health University Medical Center, Charleston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT04996875

Evaluating the Communication Between Patients and Providers in Cancer Clinics

  • Medical University of South Carolina, Charleston
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06985953

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • South Carolina Cancer Specialists PC, Hilton Head Island
  • The Radiation Oncology Center-Hilton Head/Bluffton, Hilton Head Island
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06756607

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Medical University of South Carolina, Charleston
  • Prisma Health Cancer Institute, Greenville
  • Lexington Medical Center, West Columbia
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06119581

Project: Every Child for Younger Patients With Cancer

  • Medical University of South Carolina, Charleston
  • Prisma Health Richland Hospital, Columbia
  • BI-LO Charities Children's Cancer Center, Greenville
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT02402244

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

  • START - Carolinas, Myrtle Beach
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT07480356

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Gibbs Cancer Center-Gaffney, Gaffney
  • Gibbs Cancer Center-Pelham, Greer
  • Spartanburg Medical Center, Spartanburg
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT06580314

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

  • Prisma Health Cancer Institute, Greenville
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁላይ 2026 · NCT06657144

Optimizing Care for Cancer Survivors With Depression: Project 3

  • Medical University of South Carolina, Charleston
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ጁላይ 2026 · NCT06930729

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ወንዶች · የተሻሻለው በ9 ጁላይ 2026 · NCT07103018

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

  • Medical University of South Carolina Hollings Cancer Center, Charleston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07149207

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
  • Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC, Columbia
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁን 2026 · NCT05486572

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

  • GSK Investigational Site, Myrtle Beach
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT06551142

IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)

  • Medical University of South Carolina, Charleston
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT06582784

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

  • Prisma Health-Upstate, Greenville
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06487624

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

  • Medical University of South Carolina (MUSC), Charleston
  • PRISMA Health, Institute for Translational Oncology, Greenville
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ማርች 2026 · NCT06014658

Prevent Cancer- Greenville

  • Prisma Health-Upstate, Greenville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ፌብሩ 2026 · NCT04947098

GEMINI-NSCLC: NSCLC Biomarker Study

  • The Medical University of South Carolina, Charleston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ፌብሩ 2026 · NCT05236114

Beat Childhood Cancer Specimen Banking and Data Registry

  • Medical University of South Carolina, Charleston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ3 ፌብሩ 2026 · NCT04715178

Reducing Metabolic Dysregulation in Dyads

  • University of South Carolina, Columbia
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ9 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጃንዩ 2026 · NCT06117241

Caris Biorepository Research Protocol

  • Clinical Biotechnology Research Institute at RSFH, Charleston
  • Spartanburg Regional Health Services, Spartanburg
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ጃንዩ 2026 · NCT01499394

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Greenville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

  • Carolina Blood and Cancer Care Associates, Rock Hill
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2025 · NCT06635954

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Medical University of South Carolina, Charleston
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኖቬም 2024 · NCT03860883

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።